Royalty Pharma (RPRX) Debt to Equity (2019 - 2026)
Royalty Pharma (RPRX) debt to equity from Dec 31, 2019 to Mar 31, 2026. The current Royalty Pharma (RPRX) debt to equity is 90.13%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Royalty Pharma (RPRX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 92.14% | +25.18% |
| 2024 | 73.60% | +20.98% |
| 2023 | 60.84% | -18.56% |
| 2022 | 74.71% | +7.90% |
| 2021 | 69.24% | +17.80% |
| 2020 | 58.78% | -42.13% |
| 2019 | 101.57% | N/A |
Comparison Royalty Pharma (RPRX) debt to equity with competitors
Royalty Pharma (RPRX) debt to equity is 90.13%.